Induction of the hsp70 gene promoter by various anticancer drugs

被引:15
作者
Aït-Aïssa, S
Porcher, JM [1 ]
Kretz-Remy, C
Velarde, G
Arrigo, AP
Lambre, C
机构
[1] Inst Natl Environm Ind & Risques, Lab Biochim & Toxicol Invitro, F-60550 Verneuil En Halatte, France
[2] Univ Lyon 1, CNRS UMR 5534, Ctr Genet Mol & Cellulaire, Lab Stress Cellulaire, F-69622 Villeurbanne, France
关键词
hsp70; promoter; anticancer drug; HeLa cells;
D O I
10.1016/S0887-2333(99)00032-6
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
HeLa cells containing the chloramphenicol acetyl transferase (CAT) gene under the control of the hsp70 promoter have been exposed in vitro to various anticancer drugs. Cisplatin induced CAT production with a dose-effect relationship at a non-cytotoxic dose, whereas no induction was detected with carboplatin. Etoposid induced a significant response at a cytoxic concentration. The limited positive response with doxorubicin, daunomycin and mitoxantrone was nor statistically significant. these chemicals are known to produce reactive oxygen species and induce apoptosis. No induction of the hsp70 promoter could be detected with the other cytostatic compounds that have been tested such as base analogues (5-fluorouracil, cytosine arabinoside 3'-MP), inhibitors of DNA synthesis (amethopterin, aminopterin), antimitotics (vinblastine, colchicine), and alkylating (streptozotocine, carboplatin, melphalan) or intercalating agents (bleomycin). In addition, the role of thr transcription inhibitory activity of doxorubicin in this model is evidenced and the consequent question of the suitability of the reporter gene system is discussed. Our results suggest that specific genotoxic compounds are not able to induce the hsp70 promoter, and are in agreement with the concept that stimulation of HSP70 synthesis occurs through a biochemical process involving proteotoxicity. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:651 / 655
页数:5
相关论文
共 17 条
[1]   Stress proteins (HSP) and chemical-induced autoimmunity [J].
Albers, R ;
vanderPijl, A ;
Bol, M ;
Seinen, W ;
Pieters, R .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 140 (01) :70-76
[2]   INDUCTION OF THE SMALL STRESS PROTEIN, HSP25, IN EHRLICH ASCITES-CARCINOMA CELLS BY ANTICANCER DRUGS [J].
BIELKA, H ;
HOINKIS, G ;
OESTERREICH, S ;
STAHL, J ;
BENNDORF, R .
FEBS LETTERS, 1994, 343 (02) :165-167
[3]   α-fluoro-β-alanine in urine of workers occupationally exposed to 5-fluorouracil in a 5-fluorouracil-producing factory [J].
Bos, RP ;
Weissenberger, BFJ ;
Anzion, RBM .
BIOMARKERS, 1998, 3 (01) :81-87
[4]  
CALABRESI P, 1990, PHARMACOL BASIS THER, P1202
[5]  
CHU G, 1994, J BIOL CHEM, V269, P787
[6]   BIOLOGICAL AND CLINICAL IMPLICATIONS OF HEAT-SHOCK PROTEIN 27000 (HSP27) - A REVIEW [J].
CIOCCA, DR ;
OESTERREICH, S ;
CHAMNESS, GC ;
MCGUIRE, WL ;
FUQUA, SAW .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (19) :1558-1570
[7]  
FISHBACH M, 1993, CELL BIOL TOXICOL, V9, P177
[8]  
Garrido C, 1997, CANCER RES, V57, P2661
[9]   HEAT-SHOCK, STRESS PROTEINS, CHAPERONES, AND PROTEOTOXICITY [J].
HIGHTOWER, LE .
CELL, 1991, 66 (02) :191-197
[10]   THE KINETICS OF HIV-1 LONG TERMINAL REPEAT TRANSCRIPTIONAL ACTIVATION RESEMBLE THOSE OF HSP70 PROMOTER IN HEAT-SHOCK TREATED HELA-CELLS [J].
KRETZREMY, C ;
ARRIGO, AP .
FEBS LETTERS, 1994, 351 (02) :191-196